p53: The barrier to cancer stem cell formation von Aloni-Grinstein, Ronit, Shetzer, Yoav, Kaufman, Tom, Rotter, Varda

Volltext

The paradigm of mutant p53-expressing cancer stem cells and drug resistance von Shetzer, Yoav, Solomon, Hilla, Koifman, Gabriela, Molchadsky, Alina, Horesh, Stav, Rotter, Varda

Volltext

Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers von Solomon, Hilla, Dinowitz, Nathan, Pateras, Ioannis S., Cooks, Tomer, Shetzer, Yoav, Molchadsky, Alina, Charni, Meital, Rabani, Stav, Koifman, Gabriela, Tarcic, Ohad, Porat, Ziv, Kogan-Sakin, Ira, Goldfinger, Naomi, Oren, Moshe, Harris, Curtis C., Gorgoulis, Vassilis G., Rotter, Varda

Volltext

Rescue of embryonic stem cells from cellular transformation by proteomic stabilization of mutant p53 and conversion into WT conformation von Rivlin, Noa, Katz, Shir, Doody, Maayan, Sheffer, Michal, Horesh, Stav, Molchadsky, Alina, Koifman, Gabriela, Shetzer, Yoav, Goldfinger, Naomi, Rotter, Varda, Geiger, Tamar

Volltext

Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation von Shetzer, Yoav, Molchadsky, Alina, Rotter, Varda

Volltext

A Mutant p53-Dependent Embryonic Stem Cell Gene Signature Is Associated with Augmented Tumorigenesis of Stem Cells von Koifman, Gabriela, Shetzer, Yoav, Eizenberger, Shay, Solomon, Hilla, Rotkopf, Ron, Molchadsky, Alina, Lonetto, Giuseppe, Goldfinger, Naomi, Rotter, Varda

Volltext

Immune deficiency augments the prevalence of p53 loss of heterozygosity in spontaneous tumors but not bi‐directional loss of heterozygosity in bone marrow progenitors von Shetzer, Yoav, Napchan, Yael, Kaufman, Tom, Molchadsky, Alina, Tal, Perry, Goldfinger, Naomi, Rotter, Varda

Volltext

Immune deficiency augments the prevalence of p53 loss of heterozygosity in spontaneous tumors but not bi-directional loss of heterozygosity in bone marrow progenitors: Immune defic... von Shetzer, Yoav, Napchan, Yael, Kaufman, Tom, Molchadsky, Alina, Tal, Perry, Goldfinger, Naomi, Rotter, Varda

Volltext

Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high ROS levels von Kalo, Eyal, Kogan-Sakin, Ira, Solomon, Hilla, Bar-Nathan, Elad, Shay, Moshe, Shetzer, Yoav, Dekel, Elya, Goldfinger, Naomi, Buganim, Yossi, Stambolsky, Perry, Goldstein, Ido, Madar, Shalom, Rotter, Varda

Volltext

Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species von Kalo, Eyal, Kogan-Sakin, Ira, Solomon, Hilla, Bar-Nathan, Elad, Shay, Moshe, Shetzer, Yoav, Dekel, Elya, Goldfinger, Naomi, Buganim, Yossi, Stambolsky, Perry, Goldstein, Ido, Madar, Shalom, Rotter, Varda

Volltext